HRP20220490T8 - Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije - Google Patents
Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacijeInfo
- Publication number
- HRP20220490T8 HRP20220490T8 HRP20220490TT HRP20220490T HRP20220490T8 HR P20220490 T8 HRP20220490 T8 HR P20220490T8 HR P20220490T T HRP20220490T T HR P20220490TT HR P20220490 T HRP20220490 T HR P20220490T HR P20220490 T8 HRP20220490 T8 HR P20220490T8
- Authority
- HR
- Croatia
- Prior art keywords
- psychiatric
- inflammation
- treatment
- neurological disorders
- thiazolidinone compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14170449 | 2014-05-28 | ||
EP14171024 | 2014-06-03 | ||
PCT/EP2015/061915 WO2015181337A1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
EP15725042.4A EP3148990B1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20220490T1 HRP20220490T1 (hr) | 2022-05-27 |
HRP20220490T8 true HRP20220490T8 (hr) | 2022-06-10 |
Family
ID=54698145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20220490TT HRP20220490T8 (hr) | 2014-05-28 | 2015-05-28 | Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije |
Country Status (15)
Country | Link |
---|---|
US (3) | US10155754B2 (hr) |
EP (2) | EP4011879A1 (hr) |
JP (1) | JP6671301B2 (hr) |
CN (1) | CN106660976B (hr) |
AU (2) | AU2015265865B2 (hr) |
BR (1) | BR112016027901B1 (hr) |
CA (1) | CA2950354C (hr) |
DK (1) | DK3148990T3 (hr) |
ES (1) | ES2910455T3 (hr) |
HR (1) | HRP20220490T8 (hr) |
MX (2) | MX2016015627A (hr) |
PL (1) | PL3148990T3 (hr) |
RS (1) | RS63107B1 (hr) |
RU (1) | RU2734253C2 (hr) |
WO (1) | WO2015181337A1 (hr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015181336A1 (en) * | 2014-05-28 | 2015-12-03 | Universität Bern | Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2739888A (en) * | 1954-03-29 | 1956-03-27 | Eastman Kodak Co | Photographic elements containing thiazolidine derivatives |
US2798067A (en) * | 1954-03-29 | 1957-07-02 | Eastman Kodak Co | 2-imino-4-thiazolidones and preparation |
DK1567112T3 (da) * | 2002-11-22 | 2009-02-09 | Smithkline Beecham Corp | Thiazolidin-4-oner til at hæmme hYAK3-proteiner |
CA2533638A1 (en) * | 2003-08-12 | 2005-02-24 | Amgen Inc. | Arylsulfonamidobenzylic compounds |
WO2005016227A2 (en) | 2003-08-14 | 2005-02-24 | Insight Biopharmaceuticals Ltd. | Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
CN100567275C (zh) | 2003-11-21 | 2009-12-09 | 埃科特莱茵药品有限公司 | 作为免疫抑制剂的5-(苯基-(z)-亚基)-噻唑烷-4-酮衍生物 |
EP1959958A4 (en) * | 2005-11-14 | 2010-07-14 | Univ Southern California | INTEGRIN-BINDING SMALL MOLECULES |
WO2008100977A2 (en) * | 2007-02-14 | 2008-08-21 | N.V. Organon | Carbamates therapeutic release agents as amidase inhibitors |
WO2009137133A2 (en) * | 2008-02-14 | 2009-11-12 | University Of Washington | 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
EP2435019B1 (en) | 2009-05-29 | 2015-09-23 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics |
GB201007187D0 (en) * | 2010-04-29 | 2010-06-09 | Iti Scotland Ltd | Ubiquitination modulators |
-
2015
- 2015-05-28 CN CN201580040087.8A patent/CN106660976B/zh active Active
- 2015-05-28 EP EP22152116.4A patent/EP4011879A1/en active Pending
- 2015-05-28 AU AU2015265865A patent/AU2015265865B2/en active Active
- 2015-05-28 EP EP15725042.4A patent/EP3148990B1/en active Active
- 2015-05-28 ES ES15725042T patent/ES2910455T3/es active Active
- 2015-05-28 HR HRP20220490TT patent/HRP20220490T8/hr unknown
- 2015-05-28 RS RS20220349A patent/RS63107B1/sr unknown
- 2015-05-28 DK DK15725042.4T patent/DK3148990T3/da active
- 2015-05-28 WO PCT/EP2015/061915 patent/WO2015181337A1/en active Application Filing
- 2015-05-28 MX MX2016015627A patent/MX2016015627A/es unknown
- 2015-05-28 US US15/314,067 patent/US10155754B2/en active Active
- 2015-05-28 BR BR112016027901-8A patent/BR112016027901B1/pt active IP Right Grant
- 2015-05-28 JP JP2016569730A patent/JP6671301B2/ja active Active
- 2015-05-28 PL PL15725042T patent/PL3148990T3/pl unknown
- 2015-05-28 RU RU2016147230A patent/RU2734253C2/ru active
- 2015-05-28 CA CA2950354A patent/CA2950354C/en active Active
-
2016
- 2016-11-28 MX MX2020013537A patent/MX2020013537A/es unknown
-
2018
- 2018-12-17 US US16/221,634 patent/US10392377B2/en active Active
-
2019
- 2019-08-21 US US16/546,328 patent/US10774077B2/en active Active
-
2020
- 2020-08-06 AU AU2020213369A patent/AU2020213369B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10392377B2 (en) | 2019-08-27 |
AU2015265865B2 (en) | 2020-05-07 |
US20190119265A1 (en) | 2019-04-25 |
US20190382397A1 (en) | 2019-12-19 |
EP3148990B1 (en) | 2022-01-19 |
AU2020213369A1 (en) | 2020-08-27 |
RU2734253C2 (ru) | 2020-10-13 |
DK3148990T3 (da) | 2022-04-11 |
CA2950354A1 (en) | 2015-12-03 |
RU2016147230A3 (hr) | 2018-12-25 |
RU2016147230A (ru) | 2018-07-02 |
CN106660976A (zh) | 2017-05-10 |
CA2950354C (en) | 2023-10-03 |
WO2015181337A1 (en) | 2015-12-03 |
AU2015265865A1 (en) | 2016-12-15 |
BR112016027901B1 (pt) | 2023-12-12 |
EP3148990A1 (en) | 2017-04-05 |
PL3148990T3 (pl) | 2022-05-30 |
BR112016027901A2 (pt) | 2017-08-22 |
CN106660976B (zh) | 2019-11-26 |
HRP20220490T1 (hr) | 2022-05-27 |
ES2910455T3 (es) | 2022-05-12 |
RS63107B1 (sr) | 2022-04-29 |
AU2020213369B2 (en) | 2022-09-22 |
US20170197952A1 (en) | 2017-07-13 |
MX2020013537A (es) | 2021-02-26 |
JP6671301B2 (ja) | 2020-03-25 |
MX2016015627A (es) | 2017-05-04 |
US10774077B2 (en) | 2020-09-15 |
EP4011879A1 (en) | 2022-06-15 |
JP2017516795A (ja) | 2017-06-22 |
US10155754B2 (en) | 2018-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279752B (en) | Polycyclic compounds and their use in the treatment of immune disorders | |
IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
IL247841A0 (en) | Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma | |
GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
PL3160464T3 (pl) | 6-hydroksybuspiron do stosowania w leczeniu zaburzeń ruchowych | |
IL246855A0 (en) | Materials for use in the treatment of retinitis | |
IL275349A (en) | Use of hM4Di in the treatment of seizure disorders | |
IL274838A (en) | Use of MIR101 or MIR128 in the treatment of seizure disorders | |
HRP20220490T8 (hr) | Spojevi tiazolidinona i njihova upotreba u liječenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije | |
ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
EP3371154A4 (en) | HETEROCYCLIC DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS | |
PT3148990T (pt) | Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação | |
PT3442537T (pt) | (+)-azasetrom para utilização no tratamento de doenças do ouvido | |
GB201603510D0 (en) | Compositions for use in the treatment of neurological disease |